202 related articles for article (PubMed ID: 28033293)
1. Transarterial embolization/chemoembolization therapy for hepatocellular carcinoma fed by adrenal artery: Preliminary results.
Hu S; Tu J; Jia Z; Huang Y; Jiang G
Medicine (Baltimore); 2016 Dec; 95(52):e5762. PubMed ID: 28033293
[TBL] [Abstract][Full Text] [Related]
2. Supplemental conventional transarterial embolization/chemoembolization therapy via extrahepatic arteries for hepatocellular carcinoma.
Huang Y; Jia Z; Tu J; Shen T; Tian F; Jiang G
J Cancer Res Ther; 2017; 13(4):720-724. PubMed ID: 28901321
[TBL] [Abstract][Full Text] [Related]
3. [Clinical value of transcatheter arterial chemoembolization therapy for hepatocellular carcinoma with blood supply from right adrenal artery].
Liao GS; Liu X; Luo XP; He MJ; Yang W
Zhonghua Gan Zang Bing Za Zhi; 2018 Nov; 26(11):835-841. PubMed ID: 30616318
[No Abstract] [Full Text] [Related]
4. [Extrahepatic collateral arteries are involved in the blood supply to hepatocellular carcinoma: angiographic demonstration and transcatheter arterial chemoembolization].
Li Q; Yang RJ; Zhu X; Zhu LZ; Wang MQ; Duan F
Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):613-7. PubMed ID: 24314221
[TBL] [Abstract][Full Text] [Related]
5. Supplemental transcatheter arterial chemoembolization for hepatocellular carcinoma fed by collateral omental artery.
Jia Z; Tian F; Li S; Wang K; Zhao J; Wang Y; Jiang L; Jiang G; Li M
Hepatogastroenterology; 2014 Oct; 61(135):2042-6. PubMed ID: 25713908
[TBL] [Abstract][Full Text] [Related]
6. Outcome and prognostic factors of spontaneous ruptured hepatocellular carcinoma treated with transarterial embolization.
Shin BS; Park MH; Jeon GS
Acta Radiol; 2011 Apr; 52(3):331-5. PubMed ID: 21498371
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of transcatheter embolization/chemoembolization (TAE/TACE) for the treatment of single hepatocellular carcinoma.
Miraglia R; Pietrosi G; Maruzzelli L; Petridis I; Caruso S; Marrone G; Mamone G; Vizzini G; Luca A; Gridelli B
World J Gastroenterol; 2007 Jun; 13(21):2952-5. PubMed ID: 17589945
[TBL] [Abstract][Full Text] [Related]
8. Radiotherapy plus transarterial chemoembolization for hepatocellular carcinoma invading the portal vein: long-term patient outcomes.
Yoon SM; Lim YS; Won HJ; Kim JH; Kim KM; Lee HC; Chung YH; Lee YS; Lee SG; Park JH; Suh DJ
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2004-11. PubMed ID: 21621346
[TBL] [Abstract][Full Text] [Related]
9. Clinico-roentogenologic findings in hepatocellular carcinoma fed by the right inferior phrenic artery at the initial chemoembolization.
Kimura S; Okazaki M; Higashihara H; Haruno M; Nozaki Y; Urakawa H; Kora S; Shinagawa Y; Nonokuma M
Hepatogastroenterology; 2009; 56(89):191-8. PubMed ID: 19453056
[TBL] [Abstract][Full Text] [Related]
10. C-arm Lipiodol CT in transcatheter arterial chemoembolization for small hepatocellular carcinoma.
Li JJ; Zheng JS; Cui SC; Cui XW; Hu CX; Fang D; Ye LC
World J Gastroenterol; 2015 Mar; 21(10):3035-40. PubMed ID: 25780303
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of alpha-fetoprotein status in the outcome of hepatocellular carcinoma after treatment of transarterial chemoembolization.
Wang Y; Chen Y; Ge N; Zhang L; Xie X; Zhang J; Chen R; Wang Y; Zhang B; Xia J; Gan Y; Ren Z; Ye S
Ann Surg Oncol; 2012 Oct; 19(11):3540-6. PubMed ID: 22532305
[TBL] [Abstract][Full Text] [Related]
12. Transarterial chemoembolization with cisplatin as second-line treatment for hepatocellular carcinoma unresponsive to chemoembolization with epirubicin-Lipiodol emulsion.
Maeda N; Osuga K; Higashihara H; Tomoda K; Mikami K; Nakazawa T; Nakamura H; Tomiyama N
Cardiovasc Intervent Radiol; 2012 Feb; 35(1):82-9. PubMed ID: 21203761
[TBL] [Abstract][Full Text] [Related]
13. Hepatic arterial chemoembolization for hepatocellular carcinoma: comparison of survival rates with different embolic agents.
Brown DB; Pilgram TK; Darcy MD; Fundakowski CE; Lisker-Melman M; Chapman WC; Crippin JS
J Vasc Interv Radiol; 2005 Dec; 16(12):1661-6. PubMed ID: 16371533
[TBL] [Abstract][Full Text] [Related]
14. Chemoembolization for hepatocellular carcinoma fed by right internal thoracic artery.
Shen T; Jia Z; Huang Y; Li S; Jiang G; Cheng L
Medicine (Baltimore); 2017 Nov; 96(45):e8634. PubMed ID: 29137099
[TBL] [Abstract][Full Text] [Related]
15. Predictive factors for the benefit of triple-drug transarterial chemoembolization for patients with unresectable hepatocellular carcinoma.
He M; Li Q; Shen J; Tan G; Li Q; Lai J; Wei W; Zhang Y; Zou R; Chen M; Guo R; Shi M
Cancer Med; 2019 Aug; 8(9):4200-4213. PubMed ID: 31207163
[TBL] [Abstract][Full Text] [Related]
16. Survival analysis of 230 patients with unresectable hepatocellular carcinoma treated with bland transarterial embolization.
Lanza E; Muglia R; Bolengo I; Poretti D; D'Antuono F; Ceriani R; Torzilli G; Pedicini V
PLoS One; 2020; 15(1):e0227711. PubMed ID: 31935255
[TBL] [Abstract][Full Text] [Related]
17. Combination Therapy of Radiofrequency Ablation and Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Retrospective Study.
Tang C; Shen J; Feng W; Bao Y; Dong X; Dai Y; Zheng Y; Zhang J
Medicine (Baltimore); 2016 May; 95(20):e3754. PubMed ID: 27196501
[TBL] [Abstract][Full Text] [Related]
18. Transarterial bland versus chemoembolization for hepatocellular carcinoma: rethinking a gold standard.
Massarweh NN; Davila JA; El-Serag HB; Duan Z; Temple S; May S; Sada YH; Anaya DA
J Surg Res; 2016 Feb; 200(2):552-9. PubMed ID: 26507276
[TBL] [Abstract][Full Text] [Related]
19. Transarterial chemoembolization for unresectable hepatocellular carcinoma: A comparison of the efficacy and safety of 2 embolic agents.
Chen S; Yu W; Zhang K; Liu W; Chen Q
Medicine (Baltimore); 2018 May; 97(21):e10832. PubMed ID: 29794774
[TBL] [Abstract][Full Text] [Related]
20. Long-term survival analysis in combined transarterial embolization and stereotactic body radiation therapy versus stereotactic body radiation monotherapy for unresectable hepatocellular carcinoma >5 cm.
Su TS; Lu HZ; Cheng T; Zhou Y; Huang Y; Gao YC; Tang MY; Jiang HY; Lian ZP; Hou EC; Liang P
BMC Cancer; 2016 Nov; 16(1):834. PubMed ID: 27809890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
